{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:27:13Z","timestamp":1789432033479,"version":"build-2803163510"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00702-018-1910-4","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T10:23:17Z","timestamp":1535192597000},"page":"1417-1432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Diagnostic biomarkers for Parkinson\u2019s disease at a glance: where are we?"],"prefix":"10.1007","volume":"125","author":[{"given":"Ilaria","family":"Cova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-6791","authenticated-orcid":false,"given":"Alberto","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott RD, Petrovitch H, White LR et al (2001) Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology 57:456\u2013462","journal-title":"Neurology"},{"key":"1910_CR2","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","volume":"65","author":"RD Abbott","year":"2005","unstructured":"Abbott RD, Ross GW, White LR et al (2005) Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65:1442\u20131446. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000183056.89590.0d","journal-title":"Neurology"},{"key":"1910_CR3","doi-asserted-by":"publisher","first-page":"7669","DOI":"10.1007\/s00216-016-9863-7","volume":"408","author":"S Abd-Elhadi","year":"2016","unstructured":"Abd-Elhadi S, Basora M, Vilas D et al (2016) Total \u03b1-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA. Anal Bioanal Chem 408:7669\u20137677. \n                    https:\/\/doi.org\/10.1007\/s00216-016-9863-7","journal-title":"Anal Bioanal Chem"},{"key":"1910_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11940-017-0458-1","volume":"19","author":"A Al-Qassabi","year":"2017","unstructured":"Al-Qassabi A, Fereshtehnejad S-M, Postuma RB (2017) Sleep disturbances in the prodromal stage of Parkinson disease. Curr Treat Options Neurol 19:22. \n                    https:\/\/doi.org\/10.1007\/s11940-017-0458-1","journal-title":"Curr Treat Options Neurol"},{"key":"1910_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12590","author":"AD Andersen","year":"2016","unstructured":"Andersen AD, Binzer M, Stenager E, Gramsbergen JB (2016) Cerebrospinal fluid biomarkers for Parkinson\u2019s disease\u2014a systematic review. Acta Neurol Scand. \n                    https:\/\/doi.org\/10.1111\/ane.12590","journal-title":"Acta Neurol Scand"},{"key":"1910_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JPD-150686","volume":"5","author":"RA Armstrong","year":"2015","unstructured":"Armstrong RA (2015) Oculo-visual dysfunction in Parkinson\u2019s disease. J Parkinson\u2019s Dis 5:715\u2013726. \n                    https:\/\/doi.org\/10.3233\/JPD-150686","journal-title":"J Parkinson\u2019s Dis"},{"key":"1910_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0074-7742(10)90007-X","volume":"90","author":"S Behnke","year":"2010","unstructured":"Behnke S, Schr\u00f6der U, Berg D (2010) Transcranial sonography in the premotor diagnosis of Parkinson\u2019s disease. Int Rev Neurobiol 90:93\u2013106. \n                    https:\/\/doi.org\/10.1016\/S0074-7742(10)90007-X","journal-title":"Int Rev Neurobiol"},{"key":"1910_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S1474-4422(13)70047-4","volume":"12","author":"D Berg","year":"2013","unstructured":"Berg D, Lang AE, Postuma RB et al (2013) Changing the research criteria for the diagnosis of Parkinson\u2019s disease: obstacles and opportunities. Lancet Neurol 12:514\u2013524. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70047-4","journal-title":"Lancet Neurol"},{"key":"1910_CR9","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 30:1600\u20131611. \n                    https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89\u201395. \n                    https:\/\/doi.org\/10.1067\/mcp.2001.113989","journal-title":"Clin Pharmacol Ther"},{"key":"1910_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.sleep.2006.08.017","volume":"8","author":"BF Boeve","year":"2007","unstructured":"Boeve BF, Dickson DW, Olson EJ et al (2007) Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 8:60\u201364. \n                    https:\/\/doi.org\/10.1016\/j.sleep.2006.08.017","journal-title":"Sleep Med"},{"key":"1910_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2016.11.009","volume":"35","author":"J Borgonovo","year":"2017","unstructured":"Borgonovo J, Allende-Castro C, Laliena A et al (2017) Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson\u2019s disease. Parkinsonism Relat Disord 35:17\u201324. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.009","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1910_CR14","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1212\/WNL.42.8.1631","volume":"42","author":"KL Busenbark","year":"1992","unstructured":"Busenbark KL, Huber SJ, Greer G et al (1992) Olfactory function in essential tremor. Neurology 42:1631\u20131632","journal-title":"Neurology"},{"key":"1910_CR15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00702-013-0972-6","volume":"120","author":"G Caranci","year":"2013","unstructured":"Caranci G, Piscopo P, Rivabene R et al (2013) Gender differences in Parkinson\u2019s disease: focus on plasma \u03b1-synuclein. J Neural Transm 120:1209\u20131215. \n                    https:\/\/doi.org\/10.1007\/s00702-013-0972-6\n                    \n                   (Vienna Austria 1996)","journal-title":"J Neural Transm"},{"key":"1910_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/476041","author":"MG Cersosimo","year":"2015","unstructured":"Cersosimo MG (2015) Gastrointestinal biopsies for the diagnosis of alpha-synuclein pathology in Parkinson\u2019s disease. Gastroenterol Res Pract. \n                    https:\/\/doi.org\/10.1155\/2015\/476041","journal-title":"Gastroenterol Res Pract"},{"key":"1910_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464\u2013474. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(09)70068-7","journal-title":"Lancet Neurol"},{"key":"1910_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.parkreldis.2011.02.018","volume":"17","author":"KR Chaudhuri","year":"2011","unstructured":"Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P (2011) Parkinson\u2019s disease: the non-motor issues. Parkinsonism Relat Disord 17:717\u2013723. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2011.02.018","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/345285","author":"A Chauhan","year":"2015","unstructured":"Chauhan A, Jeans AF (2015) Is Parkinson\u2019s disease truly a prion-like disorder? An appraisal of current evidence. Neurol Res Int. \n                    https:\/\/doi.org\/10.1155\/2015\/345285","journal-title":"Neurol Res Int"},{"key":"1910_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-016-0063-3","volume":"5","author":"L Chen","year":"2016","unstructured":"Chen L, Mo M, Li G et al (2016) The biomarkers of immune dysregulation and inflammation response in Parkinson disease. Transl Neurodegener 5:16. \n                    https:\/\/doi.org\/10.1186\/s40035-016-0063-3","journal-title":"Transl Neurodegener"},{"key":"1910_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"H-C Cheng","year":"2010","unstructured":"Cheng H-C, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67:715\u2013725. \n                    https:\/\/doi.org\/10.1002\/ana.21995","journal-title":"Ann Neurol"},{"key":"1910_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.22271","volume":"69","author":"AS Chen-Plotkin","year":"2011","unstructured":"Chen-Plotkin AS, Hu WT, Siderowf A et al (2011) Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol 69:655\u2013663. \n                    https:\/\/doi.org\/10.1002\/ana.22271","journal-title":"Ann Neurol"},{"key":"1910_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14802\/jmd.15015","volume":"8","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Kim SJ (2015) Metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders: a literature review. J Mov Disord 8:55\u201366. \n                    https:\/\/doi.org\/10.14802\/jmd.15015","journal-title":"J Mov Disord"},{"key":"1910_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","volume":"75","author":"DO Claassen","year":"2010","unstructured":"Claassen DO, Josephs KA, Ahlskog JE et al (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494\u2013499. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181ec7fac","journal-title":"Neurology"},{"key":"1910_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Coron E et al (2015) Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun 3:12. \n                    https:\/\/doi.org\/10.1186\/s40478-015-0196-0","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 8","key":"1910_CR26","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain J Neurol 122(Pt 8):1437\u20131448","journal-title":"Brain J Neurol"},{"key":"1910_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.870130104","volume":"13","author":"C Davie","year":"1998","unstructured":"Davie C (1998) The role of spectroscopy in parkinsonism. Mov Disord Off J Mov Disord Soc 13:2\u20134. \n                    https:\/\/doi.org\/10.1002\/mds.870130104","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/oxfordjournals.aje.a008954","volume":"144","author":"JW Davis","year":"1996","unstructured":"Davis JW, Grandinetti A, Waslien CI et al (1996) Observations on serum uric acid levels and the risk of idiopathic Parkinson\u2019s disease. Am J Epidemiol 144:480\u2013484","journal-title":"Am J Epidemiol"},{"key":"1910_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/mds.26718","volume":"31","author":"S Din Del","year":"2016","unstructured":"Del Din S, Godfrey A, Mazz\u00e0 C et al (2016) Free-living monitoring of Parkinson\u2019s disease: lessons from the field: wearable technology for Parkinson\u2019s disease. Mov Disord 31:1293\u20131313. \n                    https:\/\/doi.org\/10.1002\/mds.26718","journal-title":"Mov Disord"},{"key":"1910_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jns.2018.03.024","volume":"388","author":"ME Battista Di","year":"2018","unstructured":"Di Battista ME, Cova I, Rubino A et al (2018) Intercepting Parkinson disease non-motor subtypes: a proof-of-principle study in a clinical setting. J Neurol Sci 388:186\u2013191. \n                    https:\/\/doi.org\/10.1016\/j.jns.2018.03.024","journal-title":"J Neurol Sci"},{"key":"1910_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/mds.22963","volume":"25","author":"NJ Diederich","year":"2010","unstructured":"Diederich NJ, Pieri V, Hipp G et al (2010) Discriminative power of different nonmotor signs in early Parkinson\u2019s disease. A case\u2013control study. Mov Disord Off J Mov Disord Soc 25:882\u2013887. \n                    https:\/\/doi.org\/10.1002\/mds.22963","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ana.21327","volume":"63","author":"RL Doty","year":"2008","unstructured":"Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7\u201315. \n                    https:\/\/doi.org\/10.1002\/ana.21327","journal-title":"Ann Neurol"},{"key":"1910_CR33","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1126\/science.6505700","volume":"226","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Applebaum SL et al (1984) Smell identification ability: changes with age. Science 226:1441\u20131443","journal-title":"Science"},{"key":"1910_CR34","first-page":"237","volume":"15","author":"DA Drossman","year":"2006","unstructured":"Drossman DA, Dumitrascu DL (2006) Rome III: new standard for functional gastrointestinal disorders. J Gastrointest Liver Dis JGLD 15:237\u2013241","journal-title":"J Gastrointest Liver Dis JGLD"},{"key":"1910_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2009.08.042","volume":"289","author":"JE Duda","year":"2010","unstructured":"Duda JE (2010) Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289:49\u201354. \n                    https:\/\/doi.org\/10.1016\/j.jns.2009.08.042","journal-title":"J Neurol Sci"},{"key":"1910_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.22928","volume":"25","author":"R Duran","year":"2010","unstructured":"Duran R, Barrero FJ, Morales B et al (2010) Plasma alpha-synuclein in patients with Parkinson\u2019s disease with and without treatment. Mov Disord Off J Mov Disord Soc 25:489\u2013493. \n                    https:\/\/doi.org\/10.1002\/mds.22928","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OMA El-Agnaf","year":"2006","unstructured":"El-Agnaf OMA, Salem SA, Paleologou KE et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J Off Publ Fed Am Soc Exp Biol 20:419\u2013425. \n                    https:\/\/doi.org\/10.1096\/fj.03-1449com","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"1910_CR38","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/srep02540","volume":"3","author":"PG Foulds","year":"2013","unstructured":"Foulds PG, Diggle P, Mitchell JD et al (2013) A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci Rep 3:2540. \n                    https:\/\/doi.org\/10.1038\/srep02540","journal-title":"Sci Rep"},{"key":"1910_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/tpj.2009.60","volume":"10","author":"WM Freeman","year":"2010","unstructured":"Freeman WM, Bixler GV, Brucklacher RM et al (2010) A multistep validation process of biomarkers for preclinical drug development. Pharmacogenomics J 10:385\u2013395. \n                    https:\/\/doi.org\/10.1038\/tpj.2009.60","journal-title":"Pharmacogenomics J"},{"key":"1910_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1212\/WNL.59.4.585","volume":"59","author":"JF Gagnon","year":"2002","unstructured":"Gagnon JF, B\u00e9dard MA, Fantini ML et al (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson\u2019s disease. Neurology 59:585\u2013589","journal-title":"Neurology"},{"key":"1910_CR41","first-page":"1307","volume":"20","author":"P Gao","year":"2016","unstructured":"Gao P, Zhou P-Y, Wang P-Q et al (2016) Universality analysis of the existence of substantia nigra \u201cswallow tail\u201d appearance of non-Parkinson patients in 3\u00a0T SWI. Eur Rev Med Pharmacol Sci 20:1307\u20131314","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1910_CR42","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1212\/WNL.0b013e318198e054","volume":"72","author":"T Gasser","year":"2009","unstructured":"Gasser T (2009) Genomic and proteomic biomarkers for Parkinson disease. Neurology 72:S27\u2013S31. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318198e054","journal-title":"Neurology"},{"key":"1910_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40336-016-0171-1","volume":"4","author":"A Gerhard","year":"2016","unstructured":"Gerhard A (2016) TSPO imaging in parkinsonian disorders. Clin Transl Imaging 4:183\u2013190. \n                    https:\/\/doi.org\/10.1007\/s40336-016-0171-1","journal-title":"Clin Transl Imaging"},{"key":"1910_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/ars.2014.5859","volume":"21","author":"JG Greene","year":"2014","unstructured":"Greene JG (2014) Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson\u2019s disease. Antioxid Redox Signal 21:649\u2013667. \n                    https:\/\/doi.org\/10.1089\/ars.2014.5859","journal-title":"Antioxid Redox Signal"},{"key":"1910_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","volume":"15","author":"A Haehner","year":"2009","unstructured":"Haehner A, Boesveldt S, Berendse HW et al (2009) Prevalence of smell loss in Parkinson\u2019s disease\u2014a multicenter study. Parkinsonism Relat Disord 15:490\u2013494. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2008.12.005","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","volume":"84","author":"S Hall","year":"2015","unstructured":"Hall S, Surova Y, \u00d6hrfelt A et al (2015) CSF biomarkers and clinical progression of Parkinson disease. Neurology 84:57\u201363. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001098","journal-title":"Neurology"},{"key":"1910_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.10.011","author":"J Haqparwar","year":"2016","unstructured":"Haqparwar J, Pepe A, Fassbender K et al (2016) Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.011","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/qjmed\/92.8.473","volume":"92","author":"CH Hawkes","year":"1999","unstructured":"Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson\u2019s disease a primary olfactory disorder? QJM Mon J Assoc Physicians 92:473\u2013480","journal-title":"QJM Mon J Assoc Physicians"},{"key":"1910_CR49","volume-title":"Cooperation and competition of macrosystem outputs. Anatomy of neuropsychiatry","author":"L Heimer","year":"2008","unstructured":"Heimer L, Van Hoesen GW, Trimble M, Zahm DS (2008) Cooperation and competition of macrosystem outputs. Anatomy of neuropsychiatry. Elsevier, Amsterdam, pp\u00a0101\u2013139"},{"key":"1910_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27105","author":"A Heintz-Buschart","year":"2017","unstructured":"Heintz-Buschart A, Pandey U, Wicke T et al (2017) The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder: nose and gut microbiome in PD and iRBD. Mov Disord. \n                    https:\/\/doi.org\/10.1002\/mds.27105","journal-title":"Mov Disord"},{"key":"1910_CR51","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1572-0241.2004.04114.x","volume":"99","author":"PDR Higgins","year":"2004","unstructured":"Higgins PDR, Johanson JF (2004) Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 99:750\u2013759. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2004.04114.x","journal-title":"Am J Gastroenterol"},{"key":"1910_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jama.287.4.455","volume":"287","author":"DE Hobson","year":"2002","unstructured":"Hobson DE, Lang AE, Martin WRW et al (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287:455\u2013463","journal-title":"JAMA"},{"key":"1910_CR53","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA et al (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain J Neurol 133:713\u2013726. \n                    https:\/\/doi.org\/10.1093\/brain\/awq008","journal-title":"Brain J Neurol"},{"key":"1910_CR54","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo A, Lome\u00f1a F, Stockner H et al (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 9:1070\u20131077. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70216-7","journal-title":"Lancet Neurol"},{"key":"1910_CR55","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/mds.26055","volume":"29","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Stockner H, Serradell M et al (2014) Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord Off J Mov Disord Soc 29:1774\u20131780. \n                    https:\/\/doi.org\/10.1002\/mds.26055","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord Off J Mov Disord Soc 27:8\u201330. \n                    https:\/\/doi.org\/10.1002\/mds.23795","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR57","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.0000000000000960","volume":"83","author":"D Jennings","year":"2014","unstructured":"Jennings D, Siderowf A, Stern M et al (2014) Imaging prodromal Parkinson disease: the Parkinson associated risk syndrome Study. Neurology 83:1739\u20131746. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000960","journal-title":"Neurology"},{"key":"1910_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9831-4","author":"H Jiang","year":"2016","unstructured":"Jiang H, Huang J, Shen Y et al (2016) RBD and neurodegenerative diseases. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-016-9831-4","journal-title":"Mol Neurobiol"},{"key":"1910_CR59","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/mds.26613","volume":"31","author":"UJ Kang","year":"2016","unstructured":"Kang UJ, Goldman JG, Alcalay RN et al (2016) The BioFIND study: characteristics of a clinically typical Parkinson\u2019s disease biomarker cohort. Mov Disord Off J Mov Disord Soc 31:924\u2013932. \n                    https:\/\/doi.org\/10.1002\/mds.26613","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.parkreldis.2015.11.015","volume":"22","author":"I Kawasaki","year":"2016","unstructured":"Kawasaki I, Baba T, Takeda A, Mori E (2016) Loss of awareness of hyposmia is associated with mild cognitive impairment in Parkinson\u2019s disease. Parkinsonism Relat Disord 22:74\u201379. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.11.015","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR61","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.parkreldis.2015.04.002","volume":"21","author":"VE Kelly","year":"2015","unstructured":"Kelly VE, Johnson CO, McGough EL et al (2015) Association of cognitive domains with postural instability\/gait disturbance in Parkinson\u2019s disease. Parkinsonism Relat Disord 21:692\u2013697. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.04.002","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.01.023","volume":"26","author":"J-M Kim","year":"2016","unstructured":"Kim J-M, Jeong H-J, Bae YJ et al (2016) Loss of substantia nigra hyperintensity on 7 T MRI of Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Parkinsonism Relat Disord 26:47\u201354. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.01.023","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","volume":"32","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Krogh K, \u00d8stergaard K, Borghammer P (2017) Constipation in Parkinson\u2019s disease: subjective symptoms, objective markers, and new perspectives: constipation in Parkinson\u2019s disease. Mov Disord 32:94\u2013105. \n                    https:\/\/doi.org\/10.1002\/mds.26866","journal-title":"Mov Disord"},{"key":"1910_CR64","doi-asserted-by":"publisher","first-page":"e0123444","DOI":"10.1371\/journal.pone.0123444","volume":"10","author":"NKU Koehler","year":"2015","unstructured":"Koehler NKU, Stransky E, Meyer M et al (2015) Alpha-synuclein levels in blood plasma decline with healthy aging. PLoS One 10:e0123444. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0123444","journal-title":"PLoS One"},{"key":"1910_CR65","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","volume":"20","author":"M Kori","year":"2016","unstructured":"Kori M, Ayd\u0131n B, Unal S et al (2016) Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. Omics J Integr Biol 20:645\u2013661. \n                    https:\/\/doi.org\/10.1089\/omi.2016.0106","journal-title":"Omics J Integr Biol"},{"key":"1910_CR66","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.ncl.2016.06.012","volume":"34","author":"A Lee","year":"2016","unstructured":"Lee A, Gilbert RM (2016) Epidemiology of Parkinson disease. Neurol Clin 34:955\u2013965. \n                    https:\/\/doi.org\/10.1016\/j.ncl.2016.06.012","journal-title":"Neurol Clin"},{"key":"1910_CR67","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"PH Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HJ et al (2006) The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy. J Neural Transm 113:1435\u20131439. \n                    https:\/\/doi.org\/10.1007\/s00702-005-0427-9\n                    \n                   (Vienna Austria 1996)","journal-title":"J Neural Transm"},{"key":"1910_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlw103","author":"JM Lee","year":"2017","unstructured":"Lee JM, Derkinderen P, Kordower JH et al (2017) The search for a peripheral biopsy indicator of \u03b1-synuclein pathology for Parkinson disease. J Neuropathol Exp Neurol. \n                    https:\/\/doi.org\/10.1093\/jnen\/nlw103","journal-title":"J Neuropathol Exp Neurol"},{"key":"1910_CR69","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mds.26043","volume":"29","author":"S Leh\u00e9ricy","year":"2014","unstructured":"Leh\u00e9ricy S, Bardinet E, Poupon C et al (2014) 7 T magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 29:1574\u20131581. \n                    https:\/\/doi.org\/10.1002\/mds.26043","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR70","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2011.06.057","volume":"1408","author":"P LeWitt","year":"2011","unstructured":"LeWitt P, Schultz L, Auinger P et al (2011) CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson\u2019s disease. Brain Res 1408:88\u201397. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2011.06.057","journal-title":"Brain Res"},{"key":"1910_CR71","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","volume":"204","author":"Q-X Li","year":"2007","unstructured":"Li Q-X, Mok SS, Laughton KM et al (2007) Plasma alpha-synuclein is decreased in subjects with Parkinson\u2019s disease. Exp Neurol 204:583\u2013588. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2006.12.006","journal-title":"Exp Neurol"},{"key":"1910_CR72","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00702-010-0553-x","volume":"118","author":"I Liepelt-Scarfone","year":"2011","unstructured":"Liepelt-Scarfone I, Behnke S, Godau J et al (2011) Relation of risk factors and putative premotor markers for Parkinson\u2019s disease. J Neural Transm 118:579\u2013585. \n                    https:\/\/doi.org\/10.1007\/s00702-010-0553-x\n                    \n                   (Vienna Austria 1996)","journal-title":"J Neural Transm"},{"key":"1910_CR73","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/srep00954","volume":"2","author":"X Lin","year":"2012","unstructured":"Lin X, Cook TJ, Zabetian CP et al (2012) DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep 2:954. \n                    https:\/\/doi.org\/10.1038\/srep00954","journal-title":"Sci Rep"},{"key":"1910_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fneur.2017.00042","volume":"8","author":"G Loddo","year":"2017","unstructured":"Loddo G, Calandra-Buonaura G, Sambati L et al (2017) The treatment of sleep disorders in Parkinson\u2019s disease: from research to clinical practice. Front Neurol 8:42. \n                    https:\/\/doi.org\/10.3389\/fneur.2017.00042","journal-title":"Front Neurol"},{"key":"1910_CR75","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.parkreldis.2015.09.009","volume":"21","author":"H Luan","year":"2015","unstructured":"Luan H, Liu L-F, Tang Z et al (2015) Elevated excretion of biopyrrin as a new marker for idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 21:1371\u20131372. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.009","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR76","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5603\/NMR.2013.0007","volume":"16","author":"CG Lucio","year":"2013","unstructured":"Lucio CG, Vincenzo C, Antonio R et al (2013) Neurological applications for myocardial MIBG scintigraphy. Nucl Med Rev Cent East Eur 16:35\u201341. \n                    https:\/\/doi.org\/10.5603\/NMR.2013.0007","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"1910_CR77","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/jnnp-2013-307539","volume":"85","author":"N Magdalinou","year":"2014","unstructured":"Magdalinou N, Lees AJ, Zetterberg H (2014) Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J Neurol Neurosurg Psychiatry 85:1065\u20131075. \n                    https:\/\/doi.org\/10.1136\/jnnp-2013-307539","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1910_CR78","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.26674","volume":"31","author":"P Mahlknecht","year":"2016","unstructured":"Mahlknecht P, Gasperi A, Willeit P et al (2016) Prodromal Parkinson\u2019s disease as defined per MDS research criteria in the general elderly community. Mov Disord Off J Mov Disord Soc 31:1405\u20131408. \n                    https:\/\/doi.org\/10.1002\/mds.26674","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR79","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/mds.26932","volume":"32","author":"P Mahlknecht","year":"2017","unstructured":"Mahlknecht P, Krismer F, Poewe W, Seppi K (2017) Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson\u2019s disease: DNH on MRI as a marker for PD. Mov Disord 32:619\u2013623. \n                    https:\/\/doi.org\/10.1002\/mds.26932","journal-title":"Mov Disord"},{"key":"1910_CR80","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/archneur.59.11.1724","volume":"59","author":"C Marras","year":"2002","unstructured":"Marras C, Rochon P, Lang AE (2002) Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol 59:1724\u20131728","journal-title":"Arch Neurol"},{"key":"1910_CR81","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.parkreldis.2015.07.021","volume":"21","author":"JM Masters","year":"2015","unstructured":"Masters JM, Noyce AJ, Warner TT et al (2015) Elevated salivary protein in Parkinson\u2019s disease and salivary DJ-1 as a potential marker of disease severity. Parkinsonism Relat Disord 21:1251\u20131255. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.07.021","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR82","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2377-13-35","volume":"13","author":"DJM McGhee","year":"2013","unstructured":"McGhee DJM, Royle PL, Thompson PA et al (2013) A systematic review of biomarkers for disease progression in Parkinson\u2019s disease. BMC Neurol 13:35. \n                    https:\/\/doi.org\/10.1186\/1471-2377-13-35","journal-title":"BMC Neurol"},{"key":"1910_CR83","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"1910_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11910-015-0607-4","volume":"16","author":"SH Mehta","year":"2016","unstructured":"Mehta SH, Adler CH (2016) Advances in biomarker research in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 16:7. \n                    https:\/\/doi.org\/10.1007\/s11910-015-0607-4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1910_CR85","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/mds.10123","volume":"17","author":"M Merello","year":"2002","unstructured":"Merello M, Nouzeilles MI, Arce GP, Leiguarda R (2002) Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson\u2019s disease diagnosis. Mov Disord Off J Mov Disord Soc 17:795\u2013798. \n                    https:\/\/doi.org\/10.1002\/mds.10123","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR86","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","volume":"64","author":"DB Miller","year":"2015","unstructured":"Miller DB, O\u2019Callaghan JP (2015) Biomarkers of Parkinson\u2019s disease: present and future. Metabolism 64:S40\u2013S46. \n                    https:\/\/doi.org\/10.1016\/j.metabol.2014.10.030","journal-title":"Metabolism"},{"key":"1910_CR87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5301\/EJO.2010.1318","volume":"21","author":"MM Moschos","year":"2011","unstructured":"Moschos MM, Tagaris G, Markopoulos I et al (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24\u201329","journal-title":"Eur J Ophthalmol"},{"key":"1910_CR88","doi-asserted-by":"publisher","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","volume":"2","author":"RL Mosley","year":"2012","unstructured":"Mosley RL, Hutter-Saunders JA, Stone DK, Gendelman HE (2012) Inflammation and adaptive immunity in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009381. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a009381","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1910_CR89","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 21:10609\u201310620. \n                    https:\/\/doi.org\/10.3748\/wjg.v21.i37.10609","journal-title":"World J Gastroenterol"},{"key":"1910_CR90","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L et al (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72:893\u2013901. \n                    https:\/\/doi.org\/10.1002\/ana.23687","journal-title":"Ann Neurol"},{"key":"1910_CR91","first-page":"557583","volume-title":"Cognition in Parkinson\u2019s disease. International review of neurobiology","author":"C O\u2019Callaghan","year":"2017","unstructured":"O\u2019Callaghan C, Lewis SJG (2017) Cognition in Parkinson\u2019s disease. International review of neurobiology. Elsevier, Amsterdam, pp\u00a0557\u2013583"},{"key":"1910_CR92","first-page":"471","volume":"66","author":"I Ogawa","year":"2014","unstructured":"Ogawa I, Saito Y, Saigoh K et al (2014) The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson\u2019s disease. Brain Nerve Shinkei Kenkyu No Shinpo 66:471\u2013477","journal-title":"Brain Nerve Shinkei Kenkyu No Shinpo"},{"key":"1910_CR93","first-page":"391","volume":"79","author":"JF Pagel","year":"2009","unstructured":"Pagel JF (2009) Excessive daytime sleepiness. Am Fam Physician 79:391\u2013396","journal-title":"Am Fam Physician"},{"key":"1910_CR94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2017.02.026","volume":"38","author":"PAB Pereira","year":"2017","unstructured":"Pereira PAB, Aho VTE, Paulin L et al (2017) Oral and nasal microbiota in Parkinson\u2019s disease. Parkinsonism Relat Disord 38:61\u201367. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.026","journal-title":"Parkinsonism Relat Disord"},{"key":"1910_CR95","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ana.24291","volume":"76","author":"JS Perlmutter","year":"2014","unstructured":"Perlmutter JS, Norris SA (2014) Neuroimaging biomarkers for Parkinson disease: facts and fantasy. Ann Neurol 76:769\u2013783. \n                    https:\/\/doi.org\/10.1002\/ana.24291","journal-title":"Ann Neurol"},{"key":"1910_CR96","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11910-015-0566-9","volume":"15","author":"A Pilotto","year":"2015","unstructured":"Pilotto A, Yilmaz R, Berg D (2015) Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism. Curr Neurol Neurosci Rep 15:43. \n                    https:\/\/doi.org\/10.1007\/s11910-015-0566-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1910_CR97","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1586\/ern.12.75","volume":"12","author":"W Poewe","year":"2012","unstructured":"Poewe W, Mahlknecht P (2012) Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson\u2019s disease. Expert Rev Neurother 12:911\u2013914. \n                    https:\/\/doi.org\/10.1586\/ern.12.75","journal-title":"Expert Rev Neurother"},{"key":"1910_CR98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13167-016-0063-5","volume":"7","author":"J Polivka","year":"2016","unstructured":"Polivka J, Polivka J, Krakorova K et al (2016) Current status of biomarker research in neurology. EPMA J 7:14. \n                    https:\/\/doi.org\/10.1186\/s13167-016-0063-5","journal-title":"EPMA J"},{"key":"1910_CR99","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12:622\u2013634. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2016.152","journal-title":"Nat Rev Neurol"},{"key":"1910_CR100","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","volume":"72","author":"RB Postuma","year":"2009","unstructured":"Postuma RB, Gagnon JF, Vendette M et al (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72:1296\u20131300. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000340980.19702.6e","journal-title":"Neurology"},{"key":"1910_CR101","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 30:1591\u20131601. \n                    https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR102","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.expneurol.2004.06.001","volume":"189","author":"A Priori","year":"2004","unstructured":"Priori A, Foffani G, Pesenti A et al (2004) Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson\u2019s disease. Exp Neurol 189:369\u2013379. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2004.06.001","journal-title":"Exp Neurol"},{"key":"1910_CR103","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12026-008-8018-0","volume":"41","author":"L Qian","year":"2008","unstructured":"Qian L, Flood PM (2008) Microglial cells and Parkinson\u2019s disease. Immunol Res 41:155\u2013164. \n                    https:\/\/doi.org\/10.1007\/s12026-008-8018-0","journal-title":"Immunol Res"},{"key":"1910_CR104","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ana.23872","volume":"74","author":"JK Qiang","year":"2013","unstructured":"Qiang JK, Wong YC, Siderowf A et al (2013) Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Ann Neurol 74:119\u2013127. \n                    https:\/\/doi.org\/10.1002\/ana.23872","journal-title":"Ann Neurol"},{"key":"1910_CR105","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","volume":"73","author":"AH Rajput","year":"2009","unstructured":"Rajput AH, Voll A, Rajput ML et al (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73:206\u2013212. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181ae7af1","journal-title":"Neurology"},{"key":"1910_CR106","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.irn.2015.05.007","volume":"122","author":"M Rango","year":"2015","unstructured":"Rango M (2015) Parkinson\u2019s disease: in vivo brain metabolomics by MRS. Int Rev Neurobiol 122:81\u201394. \n                    https:\/\/doi.org\/10.1016\/bs.irn.2015.05.007","journal-title":"Int Rev Neurobiol"},{"key":"1910_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/omi.2017.0181","volume":"22","author":"S Reden\u0161ek","year":"2018","unstructured":"Reden\u0161ek S, Dol\u017ean V, Kunej T (2018) From genomics to omics landscapes of Parkinson\u2019s disease: revealing the molecular mechanisms. Omics J Integr Biol 22:1\u201316. \n                    https:\/\/doi.org\/10.1089\/omi.2017.0181","journal-title":"Omics J Integr Biol"},{"key":"1910_CR108","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JSAM Reijnders","year":"2008","unstructured":"Reijnders JSAM, Ehrt U, Weber WEJ et al (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 23:183\u2013189. \n                    https:\/\/doi.org\/10.1002\/mds.21803\n                    \n                   (quiz 313)","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR109","doi-asserted-by":"publisher","first-page":"i48","DOI":"10.1136\/jnnp.2004.060426","volume":"76","author":"H Rickards","year":"2005","unstructured":"Rickards H (2005) Depression in neurological disorders: Parkinson\u2019s disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 76:i48\u2013i52. \n                    https:\/\/doi.org\/10.1136\/jnnp.2004.060426","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1910_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00037","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J et al (2017) Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol. \n                    https:\/\/doi.org\/10.3389\/fneur.2017.00037","journal-title":"Front Neurol"},{"key":"1910_CR111","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","volume":"86","author":"G Rizzo","year":"2016","unstructured":"Rizzo G, Copetti M, Arcuti S et al (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566\u2013576. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002350","journal-title":"Neurology"},{"key":"1910_CR112","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR et al (2009) Medical records documentation of constipation preceding Parkinson disease: a case\u2013control study. Neurology 73:1752\u20131758. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34af5","journal-title":"Neurology"},{"key":"1910_CR113","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00415-009-5357-2","volume":"257","author":"P Scalzo","year":"2010","unstructured":"Scalzo P, K\u00fcmmer A, Bretas TL et al (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson\u2019s disease. J Neurol 257:540\u2013545. \n                    https:\/\/doi.org\/10.1007\/s00415-009-5357-2","journal-title":"J Neurol"},{"key":"1910_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27197","author":"F Scheperjans","year":"2017","unstructured":"Scheperjans F (2017) The prodromal microbiome: the prodromal microbiome. Mov Disord. \n                    https:\/\/doi.org\/10.1002\/mds.27197","journal-title":"Mov Disord"},{"key":"1910_CR115","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JPD-150557","volume":"5","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P (2015) Linking smoking, coffee, urate, and Parkinson\u2019s disease\u2014a role for gut microbiota? J Parkinson\u2019s Dis 5:255\u2013262. \n                    https:\/\/doi.org\/10.3233\/JPD-150557","journal-title":"J Parkinson\u2019s Dis"},{"key":"1910_CR116","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ene.12753","volume":"23","author":"SA Schneider","year":"2016","unstructured":"Schneider SA, Boettner M, Alexoudi A et al (2016) Can we use peripheral tissue biopsies to diagnose Parkinson\u2019s disease? A review of the literature. Eur J Neurol 23:247\u2013261. \n                    https:\/\/doi.org\/10.1111\/ene.12753","journal-title":"Eur J Neurol"},{"key":"1910_CR117","doi-asserted-by":"publisher","first-page":"e93814","DOI":"10.1371\/journal.pone.0093814","volume":"9","author":"ST Schwarz","year":"2014","unstructured":"Schwarz ST, Afzal M, Morgan PS et al (2014) The \u201cswallow tail\u201d appearance of the healthy nigrosome\u2014a new accurate test of Parkinson\u2019s disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS One 9:e93814. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0093814","journal-title":"PLoS One"},{"key":"1910_CR118","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","volume":"65","author":"MA Schwarzschild","year":"2008","unstructured":"Schwarzschild MA, Schwid SR, Marek K et al (2008) Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol 65:716\u2013723. \n                    https:\/\/doi.org\/10.1001\/archneur.2008.65.6.nct70003","journal-title":"Arch Neurol"},{"key":"1910_CR119","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi M, Zabetian CP, Hancock AM et al (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease. Neurosci Lett 480:78\u201382. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2010.06.009","journal-title":"Neurosci Lett"},{"key":"1910_CR120","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/mds.26411","volume":"30","author":"S Slotnick","year":"2015","unstructured":"Slotnick S, Ding Y, Glazman S et al (2015) A novel retinal biomarker for Parkinson\u2019s disease: quantifying the foveal pit with optical coherence tomography. Mov Disord Off J Mov Disord Soc 30:1692\u20131695. \n                    https:\/\/doi.org\/10.1002\/mds.26411","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1910_CR121","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ et al (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale: PIGD and the MDS-UPDRS. Mov Disord 28:668\u2013670. \n                    https:\/\/doi.org\/10.1002\/mds.25383","journal-title":"Mov Disord"},{"key":"1910_CR122","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1212\/WNL.44.2.266","volume":"44","author":"MB Stern","year":"1994","unstructured":"Stern MB, Doty RL, Dotti M et al (1994) Olfactory function in Parkinson\u2019s disease subtypes. Neurology 44:266\u2013268","journal-title":"Neurology"},{"key":"1910_CR123","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.neurobiolaging.2013.08.008","volume":"35","author":"T Stewart","year":"2014","unstructured":"Stewart T, Sui Y-T, Gonzalez-Cuyar LF et al (2014) Cheek cell-derived \u03b1-synuclein and DJ-1 do not differentiate Parkinson\u2019s disease from control. Neurobiol Aging 35:418\u2013420. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.008","journal-title":"Neurobiol Aging"},{"key":"1910_CR124","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.26907","volume":"32","author":"AP Strafella","year":"2017","unstructured":"Strafella AP, Bohnen NI, Perlmutter JS et al (2017) Molecular imaging to track Parkinson\u2019s disease and atypical parkinsonisms: new imaging frontiers: molecular imaging in parkinsonian disorders. Mov Disord 32:181\u2013192. \n                    https:\/\/doi.org\/10.1002\/mds.26907","journal-title":"Mov Disord"},{"key":"1910_CR125","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/ana.24507","volume":"78","author":"NC Swann","year":"2015","unstructured":"Swann NC, de Hemptinne C, Aron AR et al (2015) Elevated synchrony in Parkinson disease detected with electroencephalography: elevated synchrony in PD. Ann Neurol 78:742\u2013750. \n                    https:\/\/doi.org\/10.1002\/ana.24507","journal-title":"Ann Neurol"},{"key":"1910_CR126","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/mds.26022","volume":"30","author":"CR Swanson","year":"2015","unstructured":"Swanson CR, Li K, Unger TL et al (2015) Lower plasma apolipoprotein A1 levels are found in Parkinson\u2019s disease and associate with apolipoprotein A1 genotype: plasma A po A1 and APOA1 genotype in PD. Mov Disord 30:805\u2013812. \n                    https:\/\/doi.org\/10.1002\/mds.26022","journal-title":"Mov Disord"},{"key":"1910_CR127","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cortex.2015.08.005","volume":"73","author":"M Tahmasian","year":"2015","unstructured":"Tahmasian M, Bettray LM, van Eimeren T et al (2015) A systematic review on the applications of resting-state fMRI in Parkinson\u2019s disease: does dopamine replacement therapy play a role? Cortex 73:80\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.cortex.2015.08.005","journal-title":"Cortex"},{"key":"1910_CR128","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JPD-130277","volume":"4","author":"A Takeda","year":"2014","unstructured":"Takeda A, Baba T, Kikuchi A et al (2014) Olfactory dysfunction and dementia in Parkinson\u2019s disease. J Parkinson\u2019s Dis 4:181\u2013187. \n                    https:\/\/doi.org\/10.3233\/JPD-130277","journal-title":"J Parkinson\u2019s Dis"},{"key":"1910_CR129","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/BST20160334","volume":"45","author":"J-M Taymans","year":"2017","unstructured":"Taymans J-M, Mutez E, Drouyer M et al (2017) LRRK2 detection in human biofluids: potential use as a Parkinson\u2019s disease biomarker? Biochem Soc Trans 45:207\u2013212. \n                    https:\/\/doi.org\/10.1042\/BST20160334","journal-title":"Biochem Soc Trans"},{"key":"1910_CR130","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jad.2015.05.059","volume":"184","author":"E Torbey","year":"2015","unstructured":"Torbey E, Pachana NA, Dissanayaka NNW (2015) Depression rating scales in Parkinson\u2019s disease: a critical review updating recent literature. J Affect Disord 184:216\u2013224. \n                    https:\/\/doi.org\/10.1016\/j.jad.2015.05.059","journal-title":"J Affect Disord"},{"key":"1910_CR131","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.24901","volume":"81","author":"H Tremlett","year":"2017","unstructured":"Tremlett H, Bauer KC, Appel-Cresswell S et al (2017) The gut microbiome in human neurological disease: a review: gut microbiome. Ann Neurol 81:369\u2013382. \n                    https:\/\/doi.org\/10.1002\/ana.24901","journal-title":"Ann Neurol"},{"key":"1910_CR132","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/ene.12176","volume":"21","author":"KD Dijk van","year":"2014","unstructured":"van Dijk KD, Bidinosti M, Weiss A et al (2014) Reduced \u03b1-synuclein levels in cerebrospinal fluid in Parkinson\u2019s disease are unrelated to clinical and imaging measures of disease severity. Eur J Neurol 21:388\u2013394. \n                    https:\/\/doi.org\/10.1111\/ene.12176","journal-title":"Eur J Neurol"},{"key":"1910_CR133","doi-asserted-by":"publisher","first-page":"e0151156","DOI":"10.1371\/journal.pone.0151156","volume":"11","author":"G Vivacqua","year":"2016","unstructured":"Vivacqua G, Latorre A, Suppa A et al (2016) Abnormal salivary total and oligomeric alpha-synuclein in Parkinson\u2019s disease. PLoS One 11:e0151156. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0151156","journal-title":"PLoS One"},{"key":"1910_CR134","doi-asserted-by":"publisher","first-page":"121ra20","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang Y, Shi M, Chung KA et al (2012) Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci Transl Med 4:121ra20. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3002566","journal-title":"Sci Transl Med"},{"key":"1910_CR135","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","volume":"81","author":"N Wang","year":"2013","unstructured":"Wang N, Gibbons CH, Lafo J, Freeman R (2013) \u03b1-Synuclein in cutaneous autonomic nerves. Neurology 81:1604\u20131610. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9f449","journal-title":"Neurology"},{"key":"1910_CR136","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.nbd.2016.02.015","volume":"89","author":"DD Wang","year":"2016","unstructured":"Wang DD, de Hemptinne C, Miocinovic S et al (2016) Subthalamic local field potentials in Parkinson\u2019s disease and isolated dystonia: an evaluation of potential biomarkers. Neurobiol Dis 89:213\u2013222. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2016.02.015","journal-title":"Neurobiol Dis"},{"key":"1910_CR137","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww175","author":"RS Weil","year":"2016","unstructured":"Weil RS, Schrag AE, Warren JD et al (2016) Visual dysfunction in Parkinson\u2019s disease. Brain J Neurol. \n                    https:\/\/doi.org\/10.1093\/brain\/aww175","journal-title":"Brain J Neurol"},{"issue":"5 Suppl","key":"1910_CR138","first-page":"129","volume":"13","author":"A Welge-L\u00fcssen","year":"2009","unstructured":"Welge-L\u00fcssen A (2009) Ageing, neurodegeneration, and olfactory and gustatory loss. B-ENT 13(5 Suppl):129\u2013132","journal-title":"B-ENT"},{"key":"1910_CR139","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-0404.1995.tb06998.x","volume":"91","author":"GK Wenning","year":"1995","unstructured":"Wenning GK, Shephard B, Hawkes C et al (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91:247\u2013250","journal-title":"Acta Neurol Scand"},{"key":"1910_CR140","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12264-013-1390-3","volume":"30","author":"Q Xiao","year":"2014","unstructured":"Xiao Q, Chen S, Le W (2014) Hyposmia: a possible biomarker of Parkinson\u2019s disease. Neurosci Bull 30:134\u2013140. \n                    https:\/\/doi.org\/10.1007\/s12264-013-1390-3","journal-title":"Neurosci Bull"},{"key":"1910_CR141","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0809","author":"A Zhan","year":"2018","unstructured":"Zhan A, Mohan S, Tarolli C et al (2018) Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score. JAMA Neurol. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2018.0809","journal-title":"JAMA Neurol"},{"key":"1910_CR142","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2016.01.020","volume":"24","author":"K Zhu","year":"2016","unstructured":"Zhu K, van Hilten JJ, Marinus J (2016) Course and risk factors for excessive daytime sleepiness in Parkinson\u2019s disease. Parkinsonism Relat Disord 24:34\u201340. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.01.020","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1910-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1910-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1910-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T19:15:11Z","timestamp":1566674111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1910-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":142,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1910-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}